Critical

Severe / cerebral malaria

Life-threatening Plasmodium falciparum · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Severe falciparum malaria with impaired consciousness, seizures, acidosis, renal failure or shock in a returning traveller; a medical emergency.

Figures & algorithms

Blood film (thick & thin)
Blood film (thick & thin)

Red flags

  • Impaired consciousness/seizures
  • Acidosis/hyperlactataemia
  • High parasitaemia
  • Renal failure or shock

Assessment

Differential diagnosis

  • Bacterial sepsis/meningitis
  • Viral encephalitis
  • Enteric fever
  • Dengue
  • Other tropical infections

Investigations

  • Thick and thin films plus rapid antigen test (repeat if negative)
  • Parasite count, glucose, lactate
  • FBC, renal/liver function, coagulation
  • Blood cultures (exclude bacterial co-infection)

Management

  • Assess for severity criteria and support airway/breathing
  • Treat hypoglycaemia and acidosis; cautious fluids (avoid overload)
  • Give IV artesunate as first-line for severe malaria
  • Manage seizures, renal failure and anaemia supportively
  • Monitor parasite count and glucose
  • Consider bacterial co-infection and give antibiotics if shocked; ID advice

Drugs & doses

IV artesunate (antimalarial) - first line for severe malaria
IV glucose (dextrose) - for hypoglycaemia
Broad-spectrum antibiotics if concurrent bacterial sepsis suspected

Disposition

ICU/HDU with infectious diseases.

Complications & pitfalls

  • Cerebral malaria
  • AKI and acidosis
  • ARDS and hypoglycaemia

Exam pearls

  • IV artesunate is superior to quinine for severe disease
  • Avoid aggressive fluid boluses (ARDS risk)
  • Watch for delayed post-artesunate haemolysis

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.